(Q95480035)
Statements
The BCR-ABL1 T315I mutation and additional genomic aberrations are dominant genetic lesions associated with disease progression in patients with chronic myelogenous leukemia resistant to tyrosine kinase inhibitor therapy (English)
Jitka Malcikova
Filip Razga
Tomas Jurcek
Dana Dvorakova
Daniela Zackova
Martina Toskova
Ludmila Sebejova
Jana Smardova
Alexandra Oltova
Gabriela Vankova
Lenka Jurackova
Martin Trbusek
Sarka Pospisilova
Jiri Mayer